A detailed history of Advisor Group Holdings, Inc. transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 491 shares of CLDX stock, worth $12,338. This represents 0.0% of its overall portfolio holdings.

Number of Shares
491
Previous 689 28.74%
Holding current value
$12,338
Previous $25,000 36.0%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$32.06 - $44.56 $6,347 - $8,822
-198 Reduced 28.74%
491 $16,000
Q2 2024

Aug 13, 2024

SELL
$32.76 - $42.56 $2,325 - $3,021
-71 Reduced 9.34%
689 $25,000
Q1 2024

May 10, 2024

BUY
$35.22 - $51.88 $7,501 - $11,050
213 Added 38.94%
760 $31,000
Q4 2023

Feb 12, 2024

SELL
$22.61 - $40.65 $3,301 - $5,934
-146 Reduced 21.07%
547 $21,000
Q3 2023

Nov 13, 2023

SELL
$25.45 - $37.46 $2,977 - $4,382
-117 Reduced 14.44%
693 $19,000
Q2 2023

Aug 10, 2023

SELL
$30.29 - $38.28 $2,968 - $3,751
-98 Reduced 10.79%
810 $27,000
Q1 2023

May 12, 2023

SELL
$34.78 - $47.43 $1,982 - $2,703
-57 Reduced 5.91%
908 $32,000
Q4 2022

Feb 10, 2023

SELL
$27.78 - $45.38 $1,916 - $3,131
-69 Reduced 6.67%
965 $43,000
Q3 2022

Nov 14, 2022

SELL
$22.7 - $37.57 $227 - $375
-10 Reduced 0.96%
1,034 $29,000
Q2 2022

Aug 10, 2022

BUY
$20.5 - $37.33 $1,353 - $2,463
66 Added 6.75%
1,044 $28,000
Q1 2022

May 04, 2022

BUY
$27.64 - $39.32 $1,824 - $2,595
66 Added 7.24%
978 $32,000
Q3 2021

Nov 05, 2021

SELL
$28.95 - $55.99 $289 - $559
-10 Reduced 1.08%
912 $49,000
Q1 2021

May 13, 2021

SELL
$16.19 - $29.91 $210 - $388
-13 Reduced 1.39%
922 $18,000
Q4 2020

Feb 10, 2021

SELL
$14.99 - $22.75 $5,981 - $9,077
-399 Reduced 29.91%
935 $16,000
Q3 2020

Nov 12, 2020

BUY
$9.65 - $15.19 $125 - $197
13 Added 0.98%
1,334 $20,000
Q2 2020

Aug 14, 2020

BUY
$1.61 - $13.41 $590 - $4,921
367 Added 38.47%
1,321 $17,000
Q1 2020

May 18, 2020

BUY
$1.55 - $3.07 $1,478 - $2,928
954 New
954 $1,000

Others Institutions Holding CLDX

About Celldex Therapeutics, Inc.


  • Ticker CLDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,772,400
  • Market Cap $1.18B
  • Description
  • Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...
More about CLDX
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.